Capital World Investors
NAMS icon

Capital World Investors’s NewAmsterdam Pharma NAMS Stock Holding History

Capital World Investors’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414M Buy
12,230,557
+1,121,523
+10% +$37M 0.05% 242
2026
Q1 		$356M Buy
11,109,034
+1,125,034
+11% +$36.6M 0.05% 241
2025
Q4 		$350M Buy
9,984,000
+161,289
+2% +$5.87M 0.05% 238
2025
Q3 		$279M Buy
9,822,711
+1,434,986
+17% +$34.4M 0.04% 248
2025
Q2 		$152M Buy
8,387,725
+1,589,127
+23% +$29M 0.02% 300
2025
Q1 		$139M Buy
6,798,598
+5,782,522
+569% +$129M 0.02% 306
2024
Q4 		$26.1M Buy
+1,016,076
New +$21.6M ﹤0.01% 449

Other funds holding NAMS

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital World Investors's NAMS Position: Q2 2026 in Review

Capital World Investors increased its NewAmsterdam Pharma (NAMS) stake by 10% in Q2 2026, buying an estimated $37M and bringing the position to 12,230,557 shares worth $414M. The position accounts for 0.05% of the portfolio, ranked #242.

Capital World Investors first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 111 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Capital World Investors held 12,230,557 shares of NewAmsterdam Pharma worth $414M as of Q2 2026.
  • Capital World Investors bought 1,121,523 NewAmsterdam Pharma shares in Q2 2026, an estimated $37M.
  • NewAmsterdam Pharma made up 0.05% of Capital World Investors's portfolio in Q2 2026, its #242 holding.
  • Capital World Investors first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
  • 111 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.